Delivery Order SPE2DR25D3004-SPE2DR26FXVY2
- Not listed
- The Defense Logistics Agency awarded a $32,047.25 delivery order to AmerisourceBergen Drug Corp for Nitazoxanide 500 mg tablets (6-count packages) on November 24, 2025, with completion scheduled for November 25, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Nitazoxanide is an antiparasitic medication commonly used to treat various parasitic and...
- The Defense Logistics Agency awarded a delivery order valued at $3,212.33 to AmerisourceBergen Drug Corp for Nitazoxanide 500 mg tablets in quantities of six, with an ultimate completion date of August 15, 2025. This firm fixed-price, non-set-aside contract was awarded on August 14, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Nitazoxanide is an antiprotozoal and antiviral medication commonly used to treat parasitic and infectious...
- The Defense Logistics Agency awarded a $92,949.47 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Nitazoxanide 500 mg tablets (quantity 6) on January 26, 2026, with an ultimate completion date of January 27, 2026. This competitively awarded contract, which carries no set-aside designation, will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Nitazoxanide is an antiparasitic medication commonly used to treat various parasitic...
- The Defense Logistics Agency awarded a $27,816.49 delivery order to AmerisourceBergen Drug Corp for Nitazoxanide 500mg tablets (6 count) with a completion date of January 12, 2026. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle valued through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a $4,212.70 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for Nitazoxanide 500 mg tablets in quantities of six. This competitively awarded, non-set-aside contract is scheduled for ultimate completion on December 11, 2025, with performance at the vendor's Conshohocken, Pennsylvania location. The order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Nitazoxanide 500 mg tablets in quantities of six units. This firm fixed-price delivery order, valued at $3,512.48, represents a non-competitive set-aside and is scheduled for completion by November 6, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $12,027.91 to AmerisourceBergen Drug Corp for the supply of Nitazoxanide 500 mg tablets in quantities of six units. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, with an ultimate completion date of October 27, 2025. The award was made on October 24, 2025, with performance occurring at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nitazoxanide 500 mg tablets in quantities of six units, with a contract ceiling value of $25,276.20. This firm fixed-price delivery order was awarded on January 2, 2026, with an ultimate completion date of January 5, 2026, and represents a non-competitive, non-set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order valued at $6,189.10 to AmerisourceBergen Drug Corp for the supply of Nitazoxanide 500 mg tablets (quantity: 6 units) with a completion date of February 2, 2026. This is a firm fixed-price, non-set-aside contract awarded on January 30, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $5,022.83 to AmerisourceBergen Drug Corp for the supply of Nitazoxanide 500 mg tablets (quantity 6 units). This competitive, non-set-aside award was executed on November 3, 2025, with an ultimate completion date of November 4, 2025, under a firm fixed-price contract type. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- SPE2DR25D3004Indefinite Delivery Contract
- SPE2DR25D3004-SPE2DR26FXVY2Delivery Order
The Defense Logistics Agency awarded a $1,237.82 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 500 mg Nitazoxanide tablets (quantity 6) on January 29, 2026, with an ultimate completion date of January 30, 2026. This non-set-aside contract was performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Nitazoxanide is an antiprotozoal medication commonly used to treat parasitic infections and has applications within military and federal healthcare systems. The award represents a task order issued under AmerisourceBergen's existing relationship with DLA for pharmaceutical supply. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds the primary $999,999,999.00 IDC with DLA through December 2031, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs. These contracts enable AmerisourceBergen to supply a wide range of pharmaceutical products, medical devices, and healthcare commodities to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. The company competes on a full and open basis for federal medical procurement requirements and maintains a significant role in the DLA's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 1/28/26 |